臺灣癌症用藥事前審查實作指引
0.1.1 - ci-build

This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v0.1.1: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Observation: 治療後疾病狀態評估

狀態：final

治療後疾病狀態評估項目：International Working Group(IWG) Consensus Criteria (NHI-治療後疾病狀態評估項目值集#IWGC)

病人：Patient/pat-min

治療後疾病狀態評估日期：2024-01-01

治療後疾病狀態評估結果：Partial remission (PR)